Novadic-Kentron
- Address
- Hogedwarsstraat 3, 5261 LX Vught, The Netherlands
Novadic-Kentron - Addiction Medicine Research Center
Novadic-Kentron is a specialized medical research center dedicated to advancing the treatment of substance use disorders. The center focuses on developing innovative therapeutic approaches for complex addiction cases, with particular expertise in addressing emerging and challenging substance dependencies.
- GHB (gamma-hydroxybutyrate) use disorder treatment and detoxification protocols
- Pharmacological interventions for substance dependence using baclofen therapy
- Inpatient detoxification optimization and withdrawal management
The center's research program emphasizes evidence-based interventions for GHB use disorder, a particularly challenging addiction requiring specialized medical management. Current investigations explore novel baclofen add-on therapy to enhance detoxification outcomes and reduce pharmaceutical GHB requirements during inpatient treatment, representing a significant advancement in withdrawal management protocols for this difficult-to-treat condition.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 271 other sites in The Netherlands
Therapeutic Area Benchmark — The Netherlands
Select a therapeutic area to compare against other sites in The Netherlands.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: The Netherlands
Market Share
Country: The Netherlands
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Novadic-Kentron
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Baclofen as an Adjunctive Therapy for Reducing Pharmaceutical GHB Requirements in Inpatient Detoxification for GHB Use Disorder | Radboud universitair medisch centrum Stichting | Phase II | Recruiting | Jun 2025 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Baclofen | 2 | Unknown | 2025-06-16 | 2025-06-16 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.